Ligand Pharmaceuticals Inc. (OQ:LGND)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 13/19 Aug 12/19 Foehr Matthew W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,163  
Aug 13/19 Aug 12/19 Foehr Matthew W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,163 $21.92
Aug 6/19 Aug 5/19 Aryeh Jason Direct Ownership Common Stock P - Open market or private purchase 746 $90.01
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -424  
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -669  
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 424 $85.79
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 669 $56.26
Aug 5/19 Aug 2/19 Davis Todd C Direct Ownership Common Stock P - Open market or private purchase 1,000 $93.59
Aug 5/19 Aug 2/19 Patel Sunil Direct Ownership Common Stock P - Open market or private purchase 1,000 $95.98
Aug 5/19 Aug 1/19 Lamattina John L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 25th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 13/19 Aug 12/19 Foehr Matthew W Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,163  
Aug 13/19 Aug 12/19 Foehr Matthew W Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,163 $21.92
Aug 6/19 Aug 5/19 Aryeh Jason Direct Ownership Common Stock P - Open market or private purchase 746 $90.01
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -424  
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Employee Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -669  
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 424 $85.79
Aug 6/19 Aug 5/19 Berkman Charles S Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 669 $56.26
Aug 5/19 Aug 2/19 Davis Todd C Direct Ownership Common Stock P - Open market or private purchase 1,000 $93.59
Aug 5/19 Aug 1/19 Lamattina John L Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Aug 5/19 Aug 1/19 Lamattina John L Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -847 $95.58
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $LGND

StockTwits